Back to today’s briefing

Story perspectives

Lenacapavir Approved: Game-Changer for Global HIV Prevention

7/29/2025

23 4

Summary

Story summary

The European Medicines Agency has endorsed lenacapavir, a groundbreaking injectable drug for HIV prevention, emphasizing its vital role in public health. With FDA approval, this treatment could transform the fight against global HIV transmission. Yet, worries linger about accessibility in areas like Latin America, threatening progress in combating the epidemic.

1 of 1

Story summary

The European Medicines Agency has endorsed lenacapavir, a groundbreaking injectable drug for HIV prevention, emphasizing its vital role in public health. With FDA approval, this treatment could transform the fight against global HIV transmission. Yet, worries linger about accessibility in areas like Latin America, threatening progress in combating the epidemic.